CKD Bio (XKRX:063160) Accounts Payable & Accrued Expense : ₩17,066 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is CKD Bio Accounts Payable & Accrued Expense?

CKD Bio's quarterly accounts payable & accrued expense declined from Sep. 2023 (₩19,952 Mil) to Dec. 2023 (₩15,539 Mil) but then increased from Dec. 2023 (₩15,539 Mil) to Mar. 2024 (₩17,066 Mil).

CKD Bio's annual accounts payable & accrued expense increased from Dec. 2021 (₩16,917 Mil) to Dec. 2022 (₩17,533 Mil) but then declined from Dec. 2022 (₩17,533 Mil) to Dec. 2023 (₩15,539 Mil).

CKD Bio Accounts Payable & Accrued Expense Historical Data

The historical data trend for CKD Bio's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CKD Bio Accounts Payable & Accrued Expense Chart

CKD Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

30,918.09

19,777.37

16,917.32

17,532.80

15,538.71

CKD Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															16,597.14	14,765.83	19,951.76	15,538.71	17,065.62

CKD Bio Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

CKD Bio (XKRX:063160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CKD Bio Corp (XKRX:063160) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

368 Chungjeongno 3-ga, Seodaemun-gu, Seoul, KOR, 120-756

Website

http://www.ckdbio.com

CKD Bio Corp is engaged in manufacturing and distribution of pharmaceutical materials and medicines. Its products portfolio include antibiotic, lactamase inhibitors, antituberculosis, antidiabetics, immunosuppressants, antihyperlipidemics, intermediates, and probiotics.

CKD Bio (XKRX:063160) Headlines

No Headlines